Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$445K Buy
+7,080
New +$493K 0.03% 428
2024
Q3
Sell
-2,858
Closed -$324K 627
2024
Q2
$324K Sell
2,858
-25,475
-90% -$3.22M 0.1% 104
2024
Q1
$3.69M Buy
+28,333
New +$3.56M 0.3% 77

Other funds holding DXCM

NWAM LLC's DXCM Position: Q1 2026 in Review

NWAM LLC opened a new position in DexCom (DXCM) in Q1 2026: 7,080 shares worth $445K. The stake represents 0.03% of the portfolio and ranks #428 among its holdings. This is a return to the name: NWAM LLC previously reported a position in DXCM as recently as Q2 2024.

NWAM LLC first reported a position in DXCM in Q1 2024 and has held it in 3 quarters since. The position peaked at $3.69M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • NWAM LLC held 7,080 shares of DexCom worth $445K as of Q1 2026.
  • DexCom was a new NWAM LLC position in Q1 2026.
  • DexCom made up 0.03% of NWAM LLC's portfolio in Q1 2026, its #428 holding.
  • NWAM LLC first reported a position in DexCom in Q1 2024 and has held it in 3 quarters since.
  • NWAM LLC's DexCom position peaked at $3.69M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.